PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
12.91M
Better than KOD's estimated revenue of 11.32M.
-2.58M
Worse than KOD's estimated ebitda of 0.
-0.93
Better than KOD's estimated eps of -3.37.
-21.85M
Better than KOD's estimated net income of -177.34M.
-2.58M
Worse than KOD's estimated ebit of 0.
478.53M
Worse than KOD's estimated sg&a expense of 0.
Analyze DCF forecasts for the company and compare them with competitors.
1.03M
Better than KOD's revenue of 0.00.
-9.97%
Worse than KOD's revenue growth rate of 0.00%.
-33.41M
Better than KOD's ebitda of -322.80M.
-3243.20%
Worse than KOD's ebitda margin of 100.00%.
-34.10M
Better than KOD's ebit of -333.81M.
-3311.07%
Worse than KOD's ebit margin of 100.00%.
699.00K
Better than KOD's depreciation of 11.00M.
108.91M
Worse than KOD's total cash of 478.93M.
10573.79%
Better than KOD's cash as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
10.13M
Worse than KOD's accounts payable of 9.13M.
983.50%
Worse than KOD's payables as percentage of revenue of 100.00%.
-366.00K
Worse than KOD's capital expenditure of -47.36M.
-35.53%
Better than KOD's capex as percentage of revenue of 100.00%.
4.99%
Better than KOD's weighted average cost of capital (wacc) of 12.34%.
5.02%
Better than KOD's cost of equity of 15.51%.
4.08%
Worse than KOD's cost of debt of 4.06%.
-0.23
Better than KOD's beta of 2.43.
30.07M
Better than KOD's diluted shares outstanding of 52.58M.
1.57M
Better than KOD's total debt of 70.34M.
49.31M
Worse than KOD's total equity of 184.04M.
50.89M
Worse than KOD's total capital of 254.39M.
3.09%
Better than KOD's debt weighting of 27.65%.
96.91%
Better than KOD's equity weighting of 72.35%.
-32.98M
Better than KOD's ebiat of -333.81M.
-28.05M
Better than KOD's unlevered free cash flow of -373.47M.
2.00%
Equal to KOD's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Worse than KOD's net debt of -97.73M.
71.33M
Worse than KOD's equity value of 94.24M.
2.37
Better than KOD's equity value per share of 1.79.